154 related articles for article (PubMed ID: 16761394)
1. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases.
Spasova MI; Terzieva DD; Tzvetkova TZ; Stoyanova AA; Mumdzhiev IN; Yanev IB; Genev ED
Folia Med (Plovdiv); 2005; 47(3-4):46-52. PubMed ID: 16761394
[TBL] [Abstract][Full Text] [Related]
2. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
3. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia.
Heney D; Lewis IJ; Evans SW; Banks R; Bailey CC; Whicher JT
J Infect Dis; 1992 May; 165(5):886-90. PubMed ID: 1569338
[TBL] [Abstract][Full Text] [Related]
5. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer.
Urbonas V; Eidukaitė A; Tamulienė I
J Pediatr Hematol Oncol; 2012 Mar; 34(2):122-7. PubMed ID: 22367386
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.
Soker M; Colpan L; Ece A; Devecioğlu C; Haspolat K
Med Oncol; 2001; 18(1):51-7. PubMed ID: 11778970
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
[TBL] [Abstract][Full Text] [Related]
9. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
[TBL] [Abstract][Full Text] [Related]
10. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
[TBL] [Abstract][Full Text] [Related]
11. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.
Diepold M; Noellke P; Duffner U; Kontny U; Berner R
BMC Infect Dis; 2008 Mar; 8():28. PubMed ID: 18321393
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Interleukin-6, Interleukin-8, and Interleukin-10 for Predicting Bacteremia in Children with Febrile Neutropenia.
Şahbudak Bal Z; Karadaş Özdemir N; Şen S; Yılmaz Karapınar D; Azarsız E; Aydemir Ş; Vardar F
Turk J Haematol; 2017 Aug; 34(3):254-257. PubMed ID: 28148470
[TBL] [Abstract][Full Text] [Related]
14. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
15. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.
Buyukberber N; Buyukberber S; Sevinc A; Camci C
Med Oncol; 2009; 26(1):55-61. PubMed ID: 18686048
[TBL] [Abstract][Full Text] [Related]
16. Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: A prospective observational study.
Xu XJ; Luo ZB; Xia T; Song H; Yang SL; Xu WQ; Ni YR; Ning Zhao ; Tang YM
Cytokine; 2019 Apr; 116():1-6. PubMed ID: 30684912
[TBL] [Abstract][Full Text] [Related]
17. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
18. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
19. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.
Chaudhary N; Kosaraju K; Bhat K; Bairy I; Borker A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):617-23. PubMed ID: 22983415
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
